respiratori
virus
wellknown
caus
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
also
import
pathogen
concomit
pneumonia
copd
cpcopd
howev
differ
viral
infect
pattern
clinic
impact
respiratori
virus
two
group
well
investig
clinic
microbiolog
data
copd
patient
admit
aecopd
n
cpcopd
n
januari
decemb
review
exclud
patient
aecopd
cpcopd
undergo
multiplex
rtpcr
test
respiratori
virus
demograph
characterist
identifi
virus
clinic
outcom
aecopd
cpcopd
group
compar
respiratori
virus
identifi
aecopd
group
cpcopd
group
common
viru
influenza
viru
aecopd
group
versu
human
coronaviru
cpcopd
group
influenza
viru
significantli
common
aeacopd
group
cpcopd
group
p
inhospit
mortal
aecopd
cpcopd
respect
p
among
cpcopd
patient
inhospit
mortal
patient
viral
infect
group
bacteri
infect
group
viralbacteri
coinfect
respect
p
respiratori
virus
commonli
identifi
aecopd
cpcopd
influenza
viru
human
coronaviru
common
virus
identifi
aecopd
cpcopd
patient
respect
mortal
rate
viral
infect
group
significantli
lower
bacteri
infect
viralbacteri
coinfect
group
cpcopd
patient
j
med
virol
chronic
obstruct
pulmonari
diseas
copd
one
lead
global
caus
mortal
morbid
pingleton
et
al
pena
et
al
accord
recent
studi
overal
preval
copd
estim
high
world
popul
soriano
et
al
acut
exacerb
copd
aecopd
concomit
pneumonia
copd
cpcopd
two
seriou
condit
often
complic
copd
wedzicha
seemung
mullerova
et
al
respiratori
virus
wellknown
caus
aecopd
respons
aecopd
seemung
et
al
rohd
et
al
recent
newli
discov
respiratori
virus
human
metapneumoviru
human
coronaviru
bocaviru
ad
import
caus
aecopd
ringshausen
et
al
kherad
et
al
also
develop
applic
technolog
detect
viral
nucleic
acid
detect
respiratori
virus
aecopd
markedli
improv
mohan
et
al
hand
role
respiratori
virus
cpcopd
well
investig
recent
report
role
respiratori
virus
cpcopd
patient
mallia
johnston
ko
et
al
molino
et
al
vanspauwen
et
al
moreov
previou
studi
sever
limit
focus
specif
viru
influenza
viru
mallia
johnston
rtpcr
test
perform
small
portion
studi
patient
ko
et
al
molino
et
al
furthermor
best
knowledg
none
prior
studi
compar
viral
etiolog
clinic
outcom
aecopd
cpcopd
aim
investig
distribut
clinic
impact
respiratori
virus
aecopd
cpcopd
patient
retrospect
cohort
studi
perform
asan
medic
center
tertiari
referr
hospit
seoul
republ
korea
current
studi
focus
copd
patient
admit
januari
decemb
patient
admit
hospit
due
copd
studi
period
screen
diagnos
aecopd
cpcopd
includ
studi
see
definit
data
regard
clinic
outcom
microbiolog
result
collect
accord
standard
protocol
patient
admit
hospit
studi
period
first
admiss
includ
aecopd
cpcopd
group
also
clinic
sampl
obtain
patient
within
first
hr
admiss
includ
studi
studi
protocol
approv
institut
review
board
asan
medic
center
inform
consent
waiv
due
retrospect
natur
studi
diagnosi
sever
copd
defin
global
initi
chronic
obstruct
lung
diseas
gold
guidelin
vestbo
et
al
aecopd
defin
clinic
present
least
two
follow
symptom
increas
short
breath
increas
sputum
volum
purul
definit
pneumon
infiltr
chest
xray
anthonisen
et
al
cpcopd
defin
pneumonia
copd
patient
pneumonia
defin
presenc
new
radiograph
pulmonari
infiltr
plu
two
follow
fever
higher
hypothermia
ii
leukocytosi
leukopenia
white
blood
cell
iii
purul
tracheal
aspir
sputum
pingleton
et
al
mandel
et
al
microbiolog
examin
includ
gram
stain
cultur
sputum
endotrach
aspir
bronchoalveolar
lavag
bal
fluid
blood
cultur
binax
urinari
antigen
test
streptococcu
pneumonia
legionella
pneumophilia
serogroup
binax
inc
portland
pcr
assay
use
bd
probetec
et
atyp
pneumonia
assay
becton
dickinson
diagnost
system
spark
md
use
detect
atyp
pathogen
includ
mycoplasma
pneumonia
chlamydophilia
pneumonia
l
pneumophila
viral
detect
multiplex
rtpcr
kit
seeplex
ace
detect
kit
seegen
inc
seoul
korea
influenza
viru
b
respiratori
syncyti
viru
b
adenoviru
human
metapneumoviru
parainfluenza
viru
type
enteroviru
rhinoviru
human
coronaviru
use
rtpcr
kit
use
studi
valid
publish
studi
bibbi
et
al
gharabaghi
et
al
data
aecopd
cpcopd
group
compar
use
student
ttest
mannwhitney
u
test
continu
variabl
x
test
fisher
exact
test
categor
data
also
multivari
logist
regress
analysi
perform
identifi
independ
risk
factor
mortal
particularli
cpcopd
patient
variabl
show
reason
relationship
mortal
pvalu
less
univari
analysi
includ
multivari
analysi
result
express
adjust
odd
ratio
aor
confid
interv
ci
furthermor
perform
separ
x
test
inhospit
mortal
cpcopd
patient
differ
etiolog
pvalu
twotail
statist
signific
set
p
statist
analys
perform
use
spss
version
window
ibm
spss
inc
chicago
il
period
total
copd
patient
admit
asan
medic
center
patient
patient
classifi
aecopd
group
patient
classifi
cpcopd
group
exclud
patient
aecopd
cpcopd
undergo
multiplex
rtpcr
test
respiratori
virus
aecopd
patient
cpcopd
patient
final
includ
analysi
tabl
show
baselin
characterist
patient
laboratori
data
mean
age
aesd
patient
male
diabet
mellitu
common
comorbid
follow
congest
heart
failur
malign
congest
heart
failur
tend
common
aecopd
group
vs
p
recent
fev
significantli
lower
aecopd
cpcopd
group
predict
valu
vs
p
aecopd
patient
also
like
receiv
system
steroid
treatment
vs
p
home
oxygen
therapi
time
admiss
vs
p
median
valu
white
blood
cell
count
creactiv
protein
crp
level
procalcitonin
level
significantli
higher
cpcopd
patient
baselin
characterist
shown
tabl
si
analyz
respiratori
sampl
respiratori
sampl
compris
nasal
swab
sputum
sampl
n
bal
n
n
tabl
ii
includ
distribut
pathogen
identifi
one
respiratori
pathogen
identifi
aecopd
patient
cpcopd
patient
p
among
aecopd
patient
patient
viral
infect
bacteri
infect
immunosuppres
host
follow
daili
administr
corticosteroid
least
mg
per
day
prednisolon
equival
drug
ii
solid
organ
hematopoiet
stem
cell
transplant
recipi
iii
patient
receiv
chemotherapi
underli
malign
last
month
iv
patient
underli
acquir
immun
defici
disord
tabl
ii
indic
distribut
viral
pathogen
identifi
group
viral
infect
tend
common
aecopd
group
p
influenza
viru
n
commonli
identifi
viru
aecopd
group
follow
rhinoviru
n
parainfluenza
viru
n
human
coronaviru
n
contrast
human
coronaviru
common
viru
cpcopd
group
n
follow
rhinoviru
n
parainfluenza
viru
n
influenza
viru
n
influenza
viru
significantli
common
aecopd
group
cpcopd
group
vs
p
almost
influenza
viru
type
identifi
two
group
type
aecopd
cpcopd
tabl
ii
also
list
distribut
bacteri
pathogen
group
bacteri
infect
significantli
common
cpcopd
group
p
pneumonia
n
commonli
identifi
aecopd
group
follow
pseudomona
aeruginosa
n
klebsiella
pneumonia
n
staphylococcu
aureu
n
contrast
aureu
common
bacteria
cpcopd
group
n
follow
acinetobact
baumannii
n
p
aeruginosa
n
k
pneumonia
n
aureu
baumannii
significantli
common
cpcopd
group
aecopd
group
p
figur
show
season
distribut
admit
patient
studi
period
number
admit
patient
largest
winter
season
decemb
februari
group
figur
show
season
distribut
viral
pathogen
aecopd
cpcopd
influenza
viru
predomin
decemb
februari
parainfluenza
viru
human
coronaviru
mainli
present
may
novemb
januari
june
respect
human
metapneumoviru
peak
spring
season
april
may
rhinoviru
respiratori
syncyti
viru
present
throughout
year
littl
winter
season
domin
tabl
iii
compar
clinic
outcom
aecopd
cpcopd
group
despit
initi
icu
admiss
rate
significantli
differ
group
vs
p
cpcopd
patient
initi
admit
gener
ward
like
need
icu
care
aecopd
patient
hospit
stay
vs
p
among
patient
need
icu
care
median
length
icu
stay
vs
day
p
total
mechan
ventil
time
hr
vs
hr
p
significantli
longer
cpcopd
group
median
hospit
stay
significantli
longer
cpcopd
group
vs
day
p
inhospit
mortal
significantli
higher
cpcopd
group
vs
p
among
cpcopd
patient
inhospit
mortal
patient
viral
infect
group
bacteri
infect
group
viralbacteri
coinfect
respect
p
tabl
sii
howev
differ
inhospit
mortal
group
among
aecopd
patient
p
tabl
siii
result
separ
x
test
conduct
use
data
inhospit
mortal
among
cpcopd
patient
reveal
viral
infect
group
significantli
better
outcom
bacteri
infect
p
viral
bacteri
coinfect
p
group
howev
inhospit
mortal
rate
patient
bacteri
infect
alon
viralbacteri
coinfect
significantli
differ
p
univari
logist
regress
analysi
identifi
singl
viral
infect
signific
independ
predictor
day
mortal
cpcopd
patient
hazard
ratio
ci
p
singl
viral
infect
remain
signific
predict
factor
multivari
logist
regress
analysi
hazard
ratio
ci
p
tabl
siv
respiratori
virus
frequent
identifi
aecopd
cpcopd
distribut
identifi
virus
two
group
show
differ
pattern
influenza
viru
common
pathogen
aecopd
versu
human
coronaviru
cpcopd
rhinoviru
report
common
caus
aecopd
major
prior
investig
seemung
et
al
rohd
et
al
hutchinson
et
al
mcmanu
et
al
hershenson
although
human
metapneumoviru
martinello
et
al
respiratori
syncyti
viru
dimopoulo
et
al
occasion
report
common
caus
found
influenza
viru
commonli
identifi
viru
aecopd
group
follow
rhinoviru
hong
kong
group
also
show
influenza
viru
commonli
identifi
aecopd
patient
ko
et
al
howev
find
interpret
caution
studi
includ
aecopd
patient
admit
gener
hospit
therefor
bia
might
introduc
less
sever
affect
patient
come
tertiari
care
hospit
unexpectedli
human
coronaviru
commonli
identifi
viru
cpcopd
group
report
exclud
outbreak
sever
acut
respiratori
syndrom
sar
coronaviru
peiri
et
al
human
coronaviru
never
regard
common
caus
pneumonia
presenc
virus
pneumonia
patient
necessarili
mean
virus
true
pathogen
pneumonia
current
studi
cpcopd
patient
human
coronaviru
infect
bacteri
coinfect
includ
six
aureu
two
pneumonia
prior
report
show
increas
aureu
acquisit
sar
period
yap
et
al
recent
polish
group
report
human
coronaviru
increas
streptococc
adher
respiratori
epitheli
cell
golda
et
al
human
coronaviru
infect
associ
increas
plateletactiv
factor
receptor
pafr
express
promot
adher
pneumonia
studi
support
work
golda
et
al
saw
event
vitro
assay
find
suggest
human
coronaviru
infect
might
associ
risk
pneumonia
develop
bacteri
coinfect
copd
patient
studi
need
confirm
result
regard
bacteri
pathogen
identifi
present
investig
aureu
baumannii
significantli
commonli
identifi
cpcopd
group
aecopd
group
bacteria
well
known
caus
healthcar
associ
pneumonia
hcap
hospit
acquir
pneumonia
hap
yoo
et
al
howev
baumannii
list
caus
aecopd
aureu
uncommon
caus
aecopd
approxim
domenech
et
al
reissig
et
al
exposur
recent
antibiot
hospit
stay
might
influenc
type
pathogen
cpcopd
event
hospitalacquir
infect
health
care
associ
pneumonia
patient
cpcopd
aureu
group
receiv
antibiot
frequent
pathogen
group
vs
p
addit
previou
studi
perform
korea
show
aureu
baumannii
import
pathogen
particularli
hcap
hap
patient
rang
respect
choi
et
al
hong
et
al
although
aecopd
patient
greater
sever
diseas
cpcopd
patient
baselin
pulmonari
function
test
cpcopd
patient
associ
poorer
clinic
outcom
aecopd
patient
term
length
hospit
stay
hospit
mortal
found
investig
date
compar
outcom
aecopd
cpcopd
recent
spanish
group
compar
clinic
outcom
aecopd
patient
cpcopd
patient
huerta
et
al
similar
result
studi
aecopd
patient
greater
sever
diseas
cpcopd
patient
howev
result
inhospit
mortal
aecopd
group
cpcopd
group
respect
quit
differ
patient
especi
cpcopd
group
aecopd
group
cpcopd
group
thought
differ
might
reflect
differ
sever
ill
two
patient
popul
icu
admiss
rate
patient
two
group
differ
spanish
studi
aecopd
group
cpcopd
group
versu
studi
patient
differ
might
explain
outcom
differ
two
group
among
patient
viral
infect
regard
bacteri
coinfect
aecopd
patient
cpcopd
patient
bacteri
coinfect
respect
notabl
among
cpcopd
patient
viral
infect
group
significantli
better
outcom
bacteri
infect
group
viral
bacteri
coinfect
group
find
suggest
bacteri
coinfect
complic
viral
infect
lead
poorer
outcom
howev
accord
separ
x
test
mortal
rate
patient
bacteri
infect
alon
virusbacteria
coinfect
significantli
differ
thu
seem
impact
viral
infect
mortal
cpcopd
patient
bacteri
infect
may
nearli
patient
tertiari
referr
hospit
studi
popul
might
repres
gener
popul
third
virus
identifi
sensit
rtpcr
could
bystand
rather
caus
pathogen
admit
patient
neither
aecopd
cpcopd
includ
control
might
indirectli
abl
estim
proport
nonsignific
colon
howev
possibl
due
retrospect
design
studi
also
difficult
establish
causeeffect
relationship
clear
whether
peopl
develop
aecopd
cpcopd
follow
infect
fourth
studi
includ
control
patient
viral
infect
alon
without
aecopd
cpcopd
thu
difficult
determin
precis
role
viru
mortal
due
aecopd
cpcopd
also
due
retrospect
natur
studi
data
miss
exampl
difficult
obtain
accur
time
transfer
hospit
data
prior
antibiot
use
sinc
often
know
long
patient
resid
transfer
hospit
could
take
account
final
sinc
number
viru
rel
small
characterist
viral
infect
could
compar
group
conclus
respiratori
viral
infect
common
aecopd
cpcopd
howev
distribut
respiratori
virus
involv
differ
two
group
patient
clinic
outcom
cpcopd
patient
viral
infect
better
bacteri
infect
viralbacteri
coinfect
factor
associ
clinic
outcom
cpcopd
patient
includ
age
presenc
bacteri
infect
find
warrant
futur
studi
larger
scale
appropri
control
patient
yk
contribut
studi
concept
design
hck
shc
jwh
hss
sbh
cml
contribut
acquisit
data
hck
shc
yk
contribut
analysi
interpret
data
hck
shc
contribut
statist
analysi
hck
shc
yk
contribut
write
manuscript
hck
shc
jwh
sbh
cml
yk
contribut
review
accept
manuscript
yk
identifi
guarantor
paper
take
respons
integr
work
whole
incept
publish
articl
